Skip to main content
KYMR logo

KYMR · Kymera Therapeutics, Inc. · Analyst Estimates

Track KYMR — free
$115.31 -4.08 (-3.42%) At close · Nov 20 Q3 2026 earnings call transcript
Market Cap
$9.84B
Shares
85.37M
Volume · Nov 20 1.28M Avg daily vol (3M) 847.26K

Analyst Estimates

Compare analyst forecasts for Kymera Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-14 05:27 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-4.21
-3.93
-3.13
22
-3.85
-3.84
-3.78
-3.51
8
8
2
2
Revenue
USD
Publication date not stated
98.00M
99.39M
101.40M
21
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-6.70
-5.12
-3.36
22
-5.10
-5.10
-4.94
-4.36
7
7
4
5
Revenue
USD
Publication date not stated
-13.00M
42.03M
104.30M
23
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.54
-1.29
-0.78
22
-1.25
-1.27
-1.24
-1.03
6
6
4
4
Revenue
USD
Publication date not stated
-1.00M
62,500.00
2.00M
16
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.52
-1.35
-1.08
7
-1.36
-1.36
-1.26
-1.06
1
1
1
1
Revenue
USD
Publication date not stated
0.00
7.00M
20.00M
6
— — — — — — — —
Key facts CIK 1815442 CUSIP 501575104 13F (30d) 320 filings 293 filers Visit website Investor relations